• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

CYP11B2 Variant Linked to Chronic Kidney Disease Risk

by
November 11, 2026
in Health
Reading Time: 7 mins read
0
CYP11B2 Variant Linked to Chronic Kidney Disease Risk

CYP11B2 Variant Linked to Chronic Kidney Disease Risk

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A case-control study published in the Egyptian Journal of Medical Human Genetics reports that a specific genetic variant in the CYP11B2 gene is significantly associated with susceptibility to chronic kidney disease (CKD) in a North Indian cohort. The research, led by Farheen Khan and colleagues, investigated the genetic associations of two polymorphisms within the renin-angiotensin-aldosterone system (RAAS): the ACE insertion/deletion (I/D) polymorphism and the CYP11B2 -344T/C polymorphism. The findings suggest that while the ACE I/D variant did not show a significant independent association with CKD risk after adjustment, the CYP11B2 -344T/C variant demonstrated a statistically significant link to disease susceptibility.

Chronic kidney disease is characterized by the gradual and irreversible loss of kidney function, affecting approximately 10% of the global population. The condition arises from a complex interplay of environmental and genetic factors. Genes within the RAAS play a central role in regulating blood pressure, electrolyte balance, and renal hemodynamics. The ACE gene encodes the angiotensin-converting enzyme, which converts angiotensin I to angiotensin II, a potent vasoconstrictor, and degrades bradykinin. The CYP11B2 gene encodes aldosterone synthase, which catalyzes the final steps of aldosterone production. Dysregulation of these genes can contribute to hypertension, glomerular hyperfiltration, proteinuria, and renal fibrosis, all of which are hallmarks of CKD progression.

The study recruited 200 CKD patients and 180 healthy control subjects from the Department of Medicine. The diagnosis of CKD was based on the estimated glomerular filtration rate (eGFR), calculated using the 2021 CKD-EPI creatinine equation. Control subjects were unrelated individuals with normal renal function who did not have hypertension or type 2 diabetes mellitus. Participants with acute kidney injury, cardiovascular disease, sepsis, or those who were pregnant or critically ill were excluded from the study. The research was approved by the Institutional Ethical Committee and conducted in conformity with the Declaration of Helsinki.

Genotyping for the ACE I/D and CYP11B2 -344T/C polymorphisms was performed using Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) methods. DNA was extracted from peripheral blood samples collected in EDTA vials. The researchers analyzed allele and genotype frequencies using the chi-square test and assessed Hardy-Weinberg equilibrium. Additionally, in silico analysis was conducted using the AliBaba2.1 tool to predict the effect of these polymorphisms on transcription factor binding to DNA target sequences, aiming to explore potential regulatory functional relevance.

The results indicated that the ACE DD genotype was not significantly associated with CKD after adjustment for comorbidities, diet, and addiction, with an adjusted odds ratio (AOR) of 0.915 and a 95% confidence interval (CI) of 0.372–2.251. In contrast, the CYP11B2 -344T/C CT genotype showed a significant association with CKD, yielding an AOR of 0.329 and a 95% CI of 0.148–0.732. The dominant model, which included both CT and CC genotypes, also demonstrated a significant association with CKD, with an AOR of 0.425 and a 95% CI of 0.211–0.854. These findings suggest that the C allele of the CYP11B2 polymorphism may play a role in modulating susceptibility to CKD.

Furthermore, the study examined the relationship between these genotypes and renal function parameters in CKD patients. The ACE I/D polymorphism was significantly associated with variations in serum urea, creatinine, phosphorus, and eGFR levels among CKD patients, with p-values less than 0.05. Specifically, CKD patients with the DD genotype exhibited significantly lower eGFR and higher serum creatinine levels compared to those with the ID genotype. However, no statistically significant differences were observed in renal function parameters among CKD patients with different CYP11B2 genotypes, indicating that while the CYP11B2 variant may influence susceptibility, it does not appear to affect the severity of renal dysfunction in the same manner as the ACE variant.

In silico predictions using the AliBaba2.1 tool suggested potential alterations in transcription factor binding sites associated with these variants. The analysis predicted a potential loss of transcription factor binding sites in the D allele of the ACE I/D polymorphism and the C allele of the CYP11B2 -344T/C polymorphism. These predictions imply that the variants may influence gene expression through regulatory mechanisms, although the authors emphasize that these findings are exploratory and require functional validation to confirm their biological significance.

The study acknowledges several limitations that may affect the generalizability of the findings. The small sample size and single-center design limit the ability to extrapolate the results to broader populations. Additionally, the exclusion of hypertension and type 2 diabetes from the control group may have introduced selection bias, as both conditions are strongly linked to RAAS activation and CKD. The use of the AliBaba2.1 tool for in silico analysis, which is a legacy PWM-based tool, also presents limitations due to its limited accuracy and high false-positive rates. The authors recommend that future studies employ comorbidity-matched controls and larger multicenter designs to clarify the independent genetic effects of these variants.

Previous studies on the ACE I/D and CYP11B2 -344T/C polymorphisms have reported inconsistent associations with CKD across different ethnic groups and CKD phenotypes. The frequency of the ACE DD genotype in this study’s CKD cases was 17%, which was lower than frequencies reported in North Indian, Maharashtrian, South Indian, Egyptian, and Iraqi populations, but higher than in the Malaysian CKD population. Similarly, the frequency of the CYP11B2 TT genotype in CKD cases was 44.5%, which was higher than frequencies observed in Turkish, European, and Chinese CKD cases but lower than in Korean CKD cases. These variations highlight the importance of region-specific research and the potential influence of ethnic genetic heterogeneity and environmental interactions on disease susceptibility.

The findings of this study contribute to the understanding of the genetic contribution of key RAAS components to CKD risk and progression. By identifying a significant association between the CYP11B2 -344T/C polymorphism and CKD susceptibility, the research provides insights into the molecular mechanisms underlying the disease. The observed associations with renal function parameters for the ACE I/D polymorphism further suggest that these variants may have distinct roles in the pathophysiology of CKD. Understanding these genetic factors may help in clarifying inter-individual variability in CKD risk and could contribute to improved risk stratification strategies in clinical practice.

The study underscores the complexity of CKD etiology and the need for comprehensive genetic investigations. Conversely, the ACE I/D variant, while not associated with susceptibility, shows a clear link to the severity of renal dysfunction. These distinct patterns highlight the multifaceted nature of genetic influences on CKD and the importance of considering multiple genetic and environmental factors in research and clinical management.

Future research should focus on functional validation of the predicted transcription factor binding alterations to confirm their regulatory relevance. Larger multicenter studies with comorbidity-matched controls are necessary to confirm these observations and clarify their clinical relevance. Additionally, integrating these genetic findings with genome-wide association studies (GWAS) data may provide a more complete picture of the polygenic nature of CKD. The study’s results, while preliminary, offer a valuable foundation for further exploration of the genetic architecture of chronic kidney disease in North Indian populations and potentially other ethnic groups.

The study was conducted in a North Indian cohort, a region where data on these specific genetic variants remain limited. The researchers noted that previous investigations into the ACE I/D and CYP11B2 polymorphisms have yielded inconsistent results across different ethnic groups and CKD phenotypes. This variability may reflect ethnic genetic heterogeneity, environmental interactions, and differences in comorbidity profiles. By focusing on a specific geographic population, the study aims to address gaps in the literature regarding how these renin-angiotensin-aldosterone system components influence kidney disease risk in this demographic.

Genetic variation in key RAAS components is a common basis for increased system activity, which can drive hypertension and renal damage. The ACE gene, located on chromosome 17q23, contains an insertion/deletion polymorphism in intron 16 involving a 287 base pair Alu repeat. The presence or absence of this sequence may influence pre-mRNA splicing and the catalytic activity of the ACE enzyme. Similarly, the CYP11B2 gene on chromosome 8q24.3 contains a functional single-nucleotide polymorphism in the promoter region that alters transcriptional activity and aldosterone production. These regulatory changes can impact blood pressure regulation and renal hemodynamics, making them relevant candidates for assessing genetic susceptibility to renal disease.

While the CYP11B2 variant showed a significant association with CKD susceptibility, it did not correlate with the severity of renal dysfunction in the same way the ACE variant did. The study found that CYP11B2 genotypes showed no significant association with serum creatinine, urea, sodium, potassium, calcium, phosphorus, or eGFR levels among CKD patients. This pattern is consistent with findings in Korean, Chinese, and European populations. In contrast, the ACE I/D polymorphism was linked to variations in renal function parameters, suggesting that these two genetic factors may play distinct roles in the pathophysiology of chronic kidney disease.

The in silico analysis provided a mechanistic hypothesis for the observed associations. The AliBaba2.1 tool predicted that the D allele of the ACE I/D polymorphism and the C allele of the CYP11B2 -344T/C polymorphism are associated with potential losses of transcription factor binding sites. Conversely, the I allele of ACE may be associated with a potential gain of such sites. These predicted alterations in regulatory binding sites imply that the variants could influence gene expression, although the authors caution that these computational predictions are exploratory and do not establish functional regulatory effects without experimental validation.

The study’s findings align with broader genomic research indicating the polygenic nature of CKD. Large-scale genome-wide association studies involving over one million individuals have identified numerous loci associated with kidney function, but classical RAAS candidate variants like ACE I/D and CYP11B2 have not consistently emerged in these analyses. This discrepancy suggests that intermediate-frequency or rare variants with low penetrance may evade detection in standard GWAS platforms. Consequently, targeted candidate-gene investigations remain relevant for understanding specific genetic contributions to CKD risk, particularly in populations where such variants may have distinct effects.

Subject of Research: Genetic association of ACE insertion/deletion and CYP11B2 -344T/C polymorphisms with susceptibility to chronic kidney disease: a case-control study

Article Title: Genetic association of ACE insertion/deletion and CYP11B2 -344T/C polymorphisms with susceptibility to chronic kidney disease: a case-control study

Article References: Khan, F., Rizvi, S., Raza, S. T., Kumar, D., & Mahdi, F. (2026). Genetic association of ACE insertion/deletion and CYP11B2 -344T/C polymorphisms with susceptibility to chronic kidney disease: a case-control study. Egyptian Journal of Medical Human Genetics, 27(1), Article 56. https://doi.org/10.1186/s43042-026-00884-y

Image Credits: AI Generated

DOI: 10.1186/s43042-026-00884-y

Keywords: Genetic, association, insertion, deletion, CYP11B2, polymorphisms, susceptibility, chronic, kidney, disease, case-control, scientific research

News Source: Jerry Hayes. (November 11, 2026). CYP11B2 Variant Linked to Chronic Kidney Disease Risk. Scienmag.

Tags: Associationcase-controlchronicCYP11B2deletiondiseasegeneticinsertionkidneypolymorphismsscientific researchsusceptibility
Share12Tweet7Share2ShareShareShare1

Related Posts

Alcohol Attributable Conditions Drove Thirty Percent of Working Age Russian Male Deaths

Alcohol Attributable Conditions Drove Thirty Percent of Working Age Russian Male Deaths

November 20, 2026
Eurasian Woodcocks in Northwestern Türkiye Host Diverse Helminth Parasite Communities

Eurasian Woodcocks in Northwestern Türkiye Host Diverse Helminth Parasite Communities

November 20, 2026

Acellular Corneal Allografts Aid Epithelial Healing Across Diverse Nonectatic Ocular Disorders

November 20, 2026

Acupuncture Paired with Thrombolysis Shows Low Certainty Gains in Stroke Review

November 20, 2026

POPULAR NEWS

  • One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

    One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

    29 shares
    Share 12 Tweet 7
  • Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

    29 shares
    Share 12 Tweet 7
  • Predictable Human Food Prompts Alpine Choughs to Undertake Daily Routine Altitudinal Flights

    29 shares
    Share 12 Tweet 7
  • Alien Plant Spatial Metrics Vary in Reliability Under Simulated Incomplete Sampling

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Alcohol Attributable Conditions Drove Thirty Percent of Working Age Russian Male Deaths

Eurasian Woodcocks in Northwestern Türkiye Host Diverse Helminth Parasite Communities

Acellular Corneal Allografts Aid Epithelial Healing Across Diverse Nonectatic Ocular Disorders

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.